Susan Sweeney is executive vice president, Obesity and Related Conditions. She is responsible for leading a cross-functional effort focused on advancing medicines in this area.

Prior to this role, Sweeney held the position of senior vice president, Global Marketing, Access and Capabilities, where she was responsible for providing commercial leadership for Amgen products at all stages of the product lifecycle and for maximizing value across the portfolio.

Sweeney joined Amgen in September 2019. Sweeney came to Amgen from Bristol-Myers Squibb (BMS), where she led commercial activities as President of U.S. Commercial. She joined BMS in 1995 and built a legacy of industry leadership over nearly 24 years, driving sustained growth for many of the company’s most successful medicines.

Sweeney earned an MPH in Public Health from Columbia University Mailman School of Public Health and a BA from Gettysburg College.